{"id":83458,"date":"2025-07-22T15:02:11","date_gmt":"2025-07-22T15:02:11","guid":{"rendered":"https:\/\/www.europesays.com\/us\/83458\/"},"modified":"2025-07-22T15:02:11","modified_gmt":"2025-07-22T15:02:11","slug":"esoteric-testing-market-size-to-reach-usd-75-82-billion-by-2034-backed-by-growing-chronic-diseases-and-ai-innovations","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/83458\/","title":{"rendered":"Esoteric Testing Market Size to Reach USD 75.82 Billion by 2034, Backed by Growing Chronic Diseases and AI Innovations"},"content":{"rendered":"

The global esoteric
\ntesting market size<\/b><\/a> was calculated at USD 24.63 billion in 2024 and is projected
\nto grow from USD 27.56 billion in 2025 to approximately\u00a0USD 75.82 billion
\nby 2034, registering a healthy CAGR of 11.9% during the forecast period from
\n2025 to 2034, a study published by Vision Research Reports.<\/p>\n

The increased prevalence of chronic and
\ninfectious diseases and demand for personalized medicines are driving the
\nglobal esoteric testing market.<\/p>\n

\"A<\/p>\n

Note: <\/b>This report is readily
\navailable for immediate delivery. We can review it with you in a meeting to
\nensure data reliability and quality for decision-making.<\/p>\n

Preview the Report Before You Buy \u2013 Get
\nSample Pages<\/b> <\/b>\ud83d\udc49<\/b> <\/b>https:\/\/www.visionresearchreports.com\/report\/sample\/41758<\/b><\/a> <\/b><\/p>\n

Market Overview & Industry Potential<\/b><\/p>\n

The global esoteric testing market is experiencing
\nsignificant growth driven by the increased prevalence of complex diseases. The
\nmarket revolves around laboratory analysis of rare molecules and substances for
\ndiagnosing and managing complex medical conditions. The increased prevalence of
\ninfectious diseases and chronic diseases increases demand for esoteric testing,
\nincluding infectious disease testing, endocrinology testing, toxicology
\ntesting, genetic testing<\/b><\/a>, oncology testing, neurology
\ntesting, and immunology testing.<\/p>\n

The growing advancements in biotechnology<\/b><\/a> and
\ndiagnostic technologies like enzyme-linked immunosorbent assay, real-time PCR<\/b><\/a>, mass spectrometry<\/b><\/a>, flow cytometry<\/b><\/a>, next-generation sequencing,
\nand chemiluminescence immunoassay are driving the market. The expanding
\nhealthcare expenditure and growing adoption of specialized diagnostic testing
\nat driving demand for isotopic testing. Additionally, growing awareness of
\npersonalized medicine and expanding molecular testing infrastructure are
\ncontributing to the market growth.<\/p>\n

Key Takeaways <\/b><\/p>\n

\u2022\u00a0 North America led the global esoteric
\ntesting market with the largest revenue of 32% in 2024.<\/p>\n

\u2022\u00a0 Asia Pacific is expected to grow at a
\nsignificant CAGR of 13.5% from 2025 to 2034.<\/p>\n

\u2022\u00a0 By type, the oncology testing segment held the major market revenue of 29% in 2024.<\/p>\n

\u2022\u00a0 By type, the genetic testing
\nsegment will grow at a CAGR between 2025 and 2034.<\/p>\n

\u2022\u00a0 By technology, the chemiluminescence
\nimmunoassay segment held the major market revenue in 2024.<\/p>\n

\u2022\u00a0 By technology, the enzyme-linked
\nimmunosorbent assay segment will grow at a CAGR between 2025
\nand 2034.<\/p>\n

\u2022\u00a0 By end-use, the independent and
\nreference laboratories segment accounted for the major market
\nrevenue share in 2024.<\/p>\n

\u2022\u00a0 By end-use, the hospital-based
\nlaboratories segment will grow at a CAGR between 2025 and
\n2034.<\/p>\n

What are the Key Trends of the Esoteric Testing Market?<\/b><\/p>\n

\u2022\u00a0 Advancements in Diagnostic Technologies:<\/b> The
\nongoing advancements in next-generation sequencing, Singh coma flow cytometry,
\nand mass spectrometry are driving the expansion of esoteric testing for more
\naccurate and efficient diagnosis.<\/p>\n

\u2022\u00a0 Awareness of Genetic Testing:<\/b> The growing
\nawareness of genetic testing and its benefits for rare disease diagnostics and
\ncancer genomics is increasing demand for esoteric testing. <\/p>\n

Growth Factors of the Esoteric Testing Market<\/b><\/p>\n

\u2022\u00a0 Prevalence of Chronic and Infectious Diseases:<\/b> The
\nrising prevalence of chronic and infectious diseases like cancer, neurological
\ndisorders, and cardiovascular diseases is driving demand for esoteric testing.<\/p>\n

\u2022\u00a0 Expanding Applications in Oncology Research:<\/b> The
\nexpanding oncology research has increased the adoption of esoteric testing for
\nspecialized tests to help diagnose and monitor cancer.<\/p>\n

Need a Tailored Version of the Report? |
\nGet Customization Options Here: <\/b>https:\/\/www.visionresearchreports.com\/report\/customization\/41758<\/b><\/a>
\n<\/b><\/p>\n

AI Benefits to the Esoteric Testing Market<\/b><\/p>\n

AI is playing a transformative role in the esoteric testing
\nmarket by providing more efficient, accurate, and high-speed data analysis. AI
\ncan analyze complex data from the esoteric test, helping to identify potential
\npatterns and correlations that may not be apparent to a human analyst. The increasing demand for personalized medicine<\/b><\/a> is
\nbecoming easier to provide with the integration of AI in healthcare. AI offers
\ncomprehensive treatment plans for individual patient according to their unique
\ngenetic profiles, test results, and medical history. <\/p>\n

According to industry estimates, AI-driven diagnostics
\nare expected to reduce lab turnaround times by up to 30%, increasing throughput
\nfor complex esoteric tests.<\/b><\/p>\n

In March 2025<\/b>, ARUP Laboratories expanded its artificial intelligence<\/b><\/a> (AI) screening
\nalgorithm for detecting human gastrointestinal parasites to include the
\nwet-mount part of the testing method. ARUP is the first laboratory to apply AI
\nscreening to the entire ova and parasite testing process. (Source:https:\/\/www.aruplab.com\/magnify25\/biggest-advancement-parasite-screening-microscope-leveraging-artificial-intelligence#<\/a>)<\/p>\n

Major Opportunity in the Esoteric Testing Market <\/b><\/p>\n

How FDA Approvals Contribute to Growth Practices?<\/b><\/p>\n

\u00a0<\/p>\n

Discover the Full Market Insights <\/b>\ud83d\udc49 <\/b>https:\/\/www.visionresearchreports.com\/esoteric-testing-market\/41758<\/b><\/a> <\/b><\/p>\n

What are the Limitations and Challenges to the Esoteric
\nTesting Market?<\/b><\/p>\n

\u2022\u00a0 High Cost:<\/b> The esoteric testing requires expensive
\ntreatments and expertise, making it inaccessible for many patients, especially
\nin low-income communities. High costs lead to investment challenges, making it
\ndifficult for healthcare providers to provide sophisticated esoteric testing
\nservices. <\/p>\n

\u2022\u00a0 Standardization and Regulation:<\/b> The variability in
\nesoteric testing procedures and data interpretation in various labs is
\nhampering tea clinical decision-making and accurate diagnostic services.<\/p>\n

Esoteric Testing Market Report Coverage<\/b><\/p>\n\n\n

Report Attribute<\/b><\/p>\n<\/td>\n\n

Key Statistics<\/b><\/p>\n<\/td>\n<\/tr>\n\n\n

Market Size in 2025<\/p>\n<\/td>\n\n

USD 27.56 Billion<\/p>\n<\/td>\n<\/tr>\n\n\n

Market Size in 2026<\/p>\n<\/td>\n\n

USD 30.84 Billion<\/p>\n<\/td>\n<\/tr>\n\n\n

Market Size in 2030<\/p>\n<\/td>\n\n

USD 48.36 Billion<\/p>\n<\/td>\n<\/tr>\n\n\n

Market Size in 2032<\/p>\n<\/td>\n\n

USD 60.55 Billion<\/p>\n<\/td>\n<\/tr>\n\n\n

Market Size by 2034\u00a0\u00a0\u00a0 <\/p>\n<\/td>\n\n

USD 75.82\u00a0Billion<\/p>\n<\/td>\n<\/tr>\n\n\n

Growth rate from 2025 to 2034<\/p>\n<\/td>\n\n

CAGR of 11.9%<\/p>\n<\/td>\n<\/tr>\n\n\n

Base Year\u00a0<\/p>\n<\/td>\n\n

2024<\/p>\n<\/td>\n<\/tr>\n\n\n

Forecast Period<\/p>\n<\/td>\n\n

2025 to 2034<\/p>\n<\/td>\n<\/tr>\n\n\n

Segments Covered<\/p>\n<\/td>\n\n

Type, Technology and End Use<\/p>\n<\/td>\n<\/tr>\n\n\n

Companies Covered<\/p>\n<\/td>\n\n

Laboratory Corporation of America Holdings (LabCorp), Quest
\n Diagnostics Incorporated, Mayo Clinic Laboratories, Opko Health, Inc.
\n (BioReference Laboratories), ARUP Laboratories, Sonic Healthcare Limited,
\n Fulgent Genetics, Inc., Myriad Genetics, Inc., Eurofins Scientific SE,
\n Invitae Corporation<\/p>\n<\/td>\n<\/tr>\n

\u00a0<\/p>\n

For orders or inquiries, don\u2019t hesitate
\nto reach out: <\/b>sales@visionresearchreports.com<\/b><\/a><\/p>\n

Esoteric Testing Market Regional Analysis<\/b><\/p>\n

North America Esoteric Testing Market<\/b><\/p>\n

North America dominates the global esoteric testing
\nmarket<\/b>, driven by the increased prevalence of chronic and complex diseases.
\nWell-established healthcare infrastructure and growing molecular diagnosis and
\npersonalized medicines are driving innovations in the esoteric testing market.
\nThe strong presence of key market players and robust investments in research
\nand development are bringing significant innovations and growth to the market.
\nAdditionally, North America has favorable improvement policies supporting the
\nadoption of esoteric testing, contributing to the market growth. <\/p>\n

The U.S. is a major player in the additional, contributing
\nto growth due to a large population of chronic and complex diseases and a
\ngrowing focus on rare disease diagnosis. The U.S. is a hub for technological
\nadvancements, like next-generation sequencing, enabling innovation and
\ndevelopment of novel esoteric testing. The well-established healthcare
\ninfrastructure and government investments in R&D are fostering growth.<\/p>\n

\"A<\/p>\n

Asia Pacific Esoteric Testing Market <\/b><\/p>\n

Asia Pacific is the fastest-growing region in the global
\nmarket<\/b>, due to expanding healthcare expenditure, rising prevalence of
\nchronic diseases, and awareness about early diagnosis. Asia Pacific has a large
\npatient population, driving demand for sophisticated esoteric testing
\nsolutions. The growing advancements and diagnostic technologies and demand for
\npersonalized medicines are contributing to the market growth.<\/p>\n

Countries like China, Japan, and India are contributing to
\nmarket growth with large patient populations and expanding healthcare
\nexpenditure. Japan plays the significant role in the market with countries’
\nrobust focus on personalized medicines and technological advancements.
\nGovernment investments in research and development and funding for healthcare
\nfacilities are further adding to the Indian market. <\/p>\n

Segmental Analysis of the Esoteric Testing Market<\/b><\/p>\n

Why Oncology Testing Type Dominated the Esoteric Testing
\nMarket in 2024?<\/b><\/p>\n

In 2024, the oncology testing segment
\ndominated the market<\/b> due to the increased
\nprevalence of cancer and demand for advanced diagnostic solutions. The
\nadvancements in genomic testing, like next-generation
\nsequencing<\/b><\/a> enabling advancements in diagnosis and treatments for
\ncancer. The esoteric testing, used in molecular and genetic profiles, and
\nessential for early detection, prognosis, and personalized treatment plan
\nstrategies. Additionally, the growing
\ndemand for liquid biopsy<\/b><\/a> and the importance
\nof biomarker<\/b><\/a> testing are driving demand for esoteric testing in
\noncology.<\/p>\n

The <\/b>genetic testing
\nsegment is expected to lead the market in the forecast period<\/b>, driven by rising advancements in genomics and bioinformatics.
\nGenetic testing provides detailed information about the genetic makeup of an
\nindividual and helps diagnose genetic disorders. The demand for personalized
\nmedicines is driving innovations in genetic testing to provide tailored
\ntreatment plans for individual according to their unique genetic profiles.
\nGenetic testing plays a crucial role in the prevalence of genetic disorders and
\nchronic diseases, including rare disease diagnosis and cancer genomics. <\/p>\n

Which Technology Lead the Esoteric
\nTesting Market in 2024?<\/b><\/p>\n

The <\/b>chemiluminescence
\nimmunoassay segment led the market in 2024<\/b>, due to its crucial role in the identification of various
\nbiomarkers, especially in infectious disease, oncology, and endocrinology. The chemiluminescence
\nimmunoassay is highly sensitive and specific, making it valuable in esoteric
\ntesting for various diseases. The ability of chemiluminescence immunoassay
\ntechnology to detect infectious agents, hormones, cancer makers, and other
\nbiomarkers led to its higher utilization in esoteric testing.<\/p>\n

The <\/b>enzyme-linked
\nimmunosorbent assay segment is the second-largest segment<\/b>, leading the market, due to its wide use in esoteric testing for
\ninfectious disease detection, hormone level measurements, and allergy testing.
\nThe enzyme-linked immunosorbent assay technology is versatile and
\ncost-effective compared to other technologies. The easy automation nature of
\nthe technology drives its adoption in both research and diagnostic settings.
\nThe growing demand for early disease detection and advancement in enzyme-linked
\nimmunosorbent assay technology are contributing to the segment’s growth.<\/p>\n

Which End-use Dominated the Esoteric Testing Market in
\n2024?<\/b><\/p>\n

In 2024, the <\/b>independent
\nand reference laboratories segment dominated the market,<\/b> due to the large patient caseload in the independent and
\nreference laboratories. These laboratories offer specialized expertise and
\nadvanced equipment for complex esoteric tests. The laboratories are equipped to
\nhandle complex esoteric tests, including molecular, genetic, and proteomic
\ntests. The strong presence of independent and reference laboratories across the
\nglobe and collaboration with numerous healthcare providers contribute to the
\nsegment’s growth.<\/p>\n

The <\/b>hospital-based
\nlaboratories segment is expected to grow fastest over the
\nforecast period<\/b>, driven by increased demand and
\nadoption of esoteric tests in hospital-based laboratories. The growing
\nchronic diseases and hospitalizations are driving the need for advanced
\ndiagnostics. The hospital-based laboratories offer faster turnaround times and
\nintegrate with specialized patient care. Hospitals are driving a focus on
\nin-house testing, and the growing demand for on-site testing is contributing to
\nthe expansion of hospital-based laboratories.<\/p>\n

Browse More Related Insights:<\/b><\/p>\n

\u2022\u00a0 Precision Genomic Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/precision-genomic-testing-market\/41513<\/b><\/a><\/p>\n

\u2022\u00a0 Microbiology and Bacterial Culture
\nfor Industrial Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/microbiology-and-bacterial-culture-for-industrial-testing-market\/41460<\/b><\/a>
\n<\/b><\/p>\n

\u2022\u00a0 Thyroid Function Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/thyroid-function-testing-market\/41324<\/b><\/a>
\n<\/b><\/p>\n

\u2022\u00a0 U.S. Point-of-Care Glucose Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/us-point-of-care-glucose-testing-market\/41323<\/b><\/a>
\n<\/b><\/p>\n

\u2022\u00a0 Pyrogen Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/pyrogen-testing-market\/41304<\/b><\/a>
\n<\/b><\/p>\n

\u2022\u00a0 Diagnostic Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/diagnostic-testing-market\/41157<\/b><\/a>
\n<\/b><\/p>\n

\u2022\u00a0 North America Bloodstream Infection Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/north-america-bloodstream-infection-testing-market\/40807<\/b><\/a>
\n<\/b><\/p>\n

\u2022\u00a0 North America Urinary Tract Infection Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/north-america-urinary-tract-infection-testing-market\/40796<\/b><\/a>
\n<\/b><\/p>\n

\u2022\u00a0 U.S. Non Invasive Prenatal Testing Market: <\/b>https:\/\/www.visionresearchreports.com\/us-non-invasive-prenatal-testing-market\/40751<\/b><\/a>
\n<\/b><\/p>\n

What are the Key Players of the Esoteric Testing Market<\/b><\/p>\n

\u2022\u00a0 Laboratory Corporation of America Holdings <\/p>\n

\u2022\u00a0 Mayo Clinic Laboratories<\/p>\n

\u2022\u00a0 Quest Diagnostics Incorporated<\/p>\n

\u2022\u00a0 ARUP Laboratories<\/p>\n

\u2022\u00a0 Opko Health, Inc.<\/p>\n

\u2022\u00a0 Myriad Genetics, Inc.<\/p>\n

\u2022\u00a0 Invitae Corporation<\/p>\n

\u2022\u00a0 Sonic Healthcare Limited<\/p>\n

\u2022\u00a0 Eurofins Scientific SE<\/p>\n

\u2022\u00a0 Fulgent Genetics, Inc.<\/p>\n

Recent Developments in the Esoteric Testing Market <\/b><\/p>\n

\u2022\u00a0 In March 2025<\/b>, a global leader in innovation and
\ncomprehensive laboratory services, Labcorp, and its partner, OPKO Health, Inc.,
\nsigned an agreement with Labcorp for the acquisition of select assets of
\nBioReference Health, a wholly owned subsidiary of OPKO Health, Inc. (Source:https:\/\/www.opko.com\/investors\/news-events\/press-releases\/detail\/516\/labcorp-announces-acquisition-of-select-assets-of-bioreference-healths-innovative-oncology-and-related-clinical-testing-services-businesses<\/a>)<\/p>\n

\u2022\u00a0 In January 2025<\/b>, bioM\u00e9rieux, a global leader in
\nthe in vitro diagnostics field, agreed to acquire SpinChip Diagnostics ASA, a
\nprivately held Norwegian diagnostics company that developed a comprehensive
\nimmunoassay diagnostic platform. (Source:https:\/\/www.biomerieux.com\/content\/dam\/biomerieux-com\/investor\/regulated-informations\/2025\/press-releases\/PR_bioMerieux_acquisition_SpinChip_20250113.pdf<\/a>)<\/p>\n

Segment Covered in the Report<\/b><\/p>\n

By Type<\/b><\/p>\n

\u2022\u00a0 Oncology testing<\/p>\n

\u2022\u00a0 Infectious disease testing<\/p>\n

\u2022\u00a0 Genetic testing<\/p>\n

\u2022\u00a0 Endocrinology testing<\/p>\n

\u2022\u00a0 Toxicology testing<\/p>\n

\u2022\u00a0 Neurology testing<\/p>\n

\u2022\u00a0 Others <\/p>\n

By Technology<\/b><\/p>\n

\u2022\u00a0 Chemiluminescence immunoassay<\/p>\n

\u2022\u00a0 Enzyme-linked immunosorbent assay<\/p>\n

\u2022\u00a0 Mass spectrometry<\/p>\n

\u2022\u00a0 Real-time polymerase chain reaction<\/p>\n

\u2022\u00a0 Flow cytometry<\/p>\n

\u2022\u00a0 Others <\/p>\n

By End-use<\/b><\/p>\n

\u2022\u00a0 Hospital-based laboratories<\/p>\n

\u2022\u00a0 Independent and reference laboratories<\/p>\n

\u2022\u00a0 Others <\/p>\n

By Region<\/b><\/p>\n

\u2022\u00a0 North America<\/p>\n

\u2022\u00a0 U.S.<\/p>\n

\u2022\u00a0 Canada<\/p>\n

\u2022\u00a0 Mexico<\/p>\n

\u2022\u00a0 Europe<\/p>\n

\u2022\u00a0 UK<\/p>\n

\u2022\u00a0 Germany<\/p>\n

\u2022\u00a0 France<\/p>\n

\u2022\u00a0 Italy<\/p>\n

\u2022\u00a0 Spain<\/p>\n

\u2022\u00a0 Denmark<\/p>\n

\u2022\u00a0 Sweden<\/p>\n

\u2022\u00a0 Norway<\/p>\n

\u2022\u00a0 Asia Pacific<\/p>\n

\u2022\u00a0 China<\/p>\n

\u2022\u00a0 Japan<\/p>\n

\u2022\u00a0 India<\/p>\n

\u2022\u00a0 South Korea<\/p>\n

\u2022\u00a0 Australia<\/p>\n

\u2022\u00a0 Thailand<\/p>\n

\u2022\u00a0 Rest of Asia
\nPacific<\/p>\n

\u2022\u00a0 Latin America<\/p>\n

\u2022\u00a0 Brazil<\/p>\n

\u2022\u00a0 Argentina<\/p>\n

\u2022\u00a0 Rest of Latin
\nAmerica<\/p>\n

\u2022\u00a0 Middle East & Africa (MEA)<\/p>\n

\u2022\u00a0 South Africa<\/p>\n

\u2022\u00a0 Saudi Arabia<\/p>\n

\u2022\u00a0 UAE<\/p>\n

\u2022\u00a0 Kuwait<\/p>\n

Instant Delivery Available | Purchase
\nThis Exclusive Research Report Now!<\/b> https:\/\/www.visionresearchreports.com\/report\/checkout\/41758<\/b><\/a>\n<\/p>\n

You can place an
\norder or ask any questions, please feel free to contact at<\/b><\/a> sales@visionresearchreports.com<\/b><\/a>\n<\/p>\n

About Us<\/b><\/p>\n

Vision Research Reports is a premier
\nservice provider offering strategic market insights and solutions that go
\nbeyond traditional surveys. We specialize in actionable market research,
\ndelivering in-depth qualitative insights and strategies to global industry
\nleaders and executives, helping them navigate future uncertainties. Our
\nofferings include consulting services, syndicated market studies, and bespoke
\nresearch reports.<\/p>\n

We are committed to excellence in
\nqualitative market research, fostering a team of experts with deep industry
\nknowledge. Our goal is to help clients understand both current and future
\nmarket trends, empowering them to expand their portfolios and achieve their
\nbusiness objectives with the right guidance.<\/p>\n

Web: <\/b>https:\/\/www.visionresearchreports.com\/<\/b><\/a>\n<\/p>\n

Our Trusted Data Partners<\/b><\/p>\n

Precedence
\nResearch<\/b><\/a>\u00a0|\u00a0<\/b>Statifacts<\/b><\/a>\u00a0|\u00a0\u00a0<\/b>Nova
\nOne Advisor<\/b><\/a> <\/p>\n

For Latest Update Follow Us: <\/b>https:\/\/www.linkedin.com\/company\/vision-research-report<\/b><\/a> \u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"The global esoteric testing market size was calculated at USD 24.63 billion in 2024 and is projected to…\n","protected":false},"author":3,"featured_media":83459,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[815,159,67,132,68],"class_list":{"0":"post-83458","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-science","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114897495191510641","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/83458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=83458"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/83458\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/83459"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=83458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=83458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=83458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}